e-Article
Efficacy and Safety of Dupilumab Maintained in Adults >= 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials (vol 24, pg 469, 2023)
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
11791888